🚀 Exciting News! endogene.bio, has been named a laureate of the i-Lab 2024 Innovation Competition! Our awarded project is assessing drug response in endometriosis patients 💛. We are proud to be among the 177 projects supported through #France2030. Thank you to the French Governement, ADEME, and Bpifrance for their support. 🫶 And above all, thank you to our fantastic endogene.bio team, for all the hard work you put in everyday to build a better future for female health! #FemaleHealth #Endometriosis #iLab2024 #France2030
À propos
EndoGene.Bio is dedicated to molecular biomarker discovery in female health. We look at epigenetic markers in menstrual blood. Our first target is the development of non-invasive biomarkers for better endometriosis diagnosis and management.
- Site web
-
https://endogene.bio/
Lien externe pour endogene.bio
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 2-10 employés
- Siège social
- Paris, France
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2022
Lieux
-
Principal
Station F
75013 Paris, France, FR
Employés chez endogene.bio
-
Cemsel Bafligil Suomi, PhD
Senior Bioinformatics Scientist @ EndoGene.Bio
-
Ioanna Tiniakou
Immunologist / Research scientist
-
Sarah Harden, PhD, AFHEA
Endometriosis Scientist | Research Associate | Women's health | Molecular Biology | Cell Biology | Oncology | Views my own
-
Raúl Pérez Moraga
Bioinformatics Scientist
Nouvelles
-
Thank you, Healthcare Businesswomen’s Association, for the opportunity to pitch and share our work. We also look forward to connecting with your talented members to explore opportunities for collaboration. Together, we can drive meaningful advancements in female health! #HBAAC24 #HBAPitch #HBAimpact
Breaking News: 8 companies have been selected to participate in our first-ever Pitch Competition for Women Innovators, taking place 25 September at #HBAAC24. This groundbreaking event aims to address the significant funding gap faced by women entrepreneurs in healthcare and life sciences, where only 3% of venture capital funding goes to female founders, and an even smaller percentage to women of color. More than $100K in cash prizes will be awarded to the 1st place, 2nd place, and Audience Choice winners collectively. Participants include: Bfree Cup; Cura Therapeutics Inc.; endogene.bio; FemTherapeutics; HDAX Therapeutics; ImaginAble Solutions; Scotiaderm; Vessl Prosthetics Read the full release: https://lnkd.in/eW5Qafr2 #HBAimpact #genderequity #womeninnovators #healthcare HBA Canada Region
-
✨ Exciting News to share! ✨ We are excited to welcome Raúl Pérez Moraga to our team as a Bioinformatics Scientist, focusing on women's health. With over six years of experience in bioinformatics and data science, Raúl brings a wealth of expertise in developing and implementing cutting-edge genomic and transcriptomic analyses. His extensive background includes designing scRNA-seq pipelines and contributing to significant projects related to conditions such as Asherman syndrome and myometrium atlas, with his work being recognized and published in top-tier scientific journals. Raúl's proficiency in advanced NGS methodologies, machine learning, and deep learning, along with his coding skills, will be invaluable in driving our mission forward. We are confident that Raúl's contributions will significantly enhance our research capabilities and help us achieve our goal of advancing women's health through innovative bioinformatics solutions. Welcome onboard, Raúl! 🚀🚀
-
Just wrapped up ESHRE 2024! 🇳🇱 María Teresa Pérez Zaballos and Sarah Harden, PhD, AFHEA were in Amsterdam earlier this week to attend this year's European Society of Human Reproduction and Embryology (ESHRE) conference. This was a fantastic opportunity to connect with fellow professionals and researchers passionate about reproductive health. The conference offered a wealth of insights into the latest advancements. #eshre2024 #reproductivehealth #endometriosis
-
🌟 Exciting Announcement 🌟 We are delighted to share that our very own Sarah Harden, PhD, AFHEA has been recognised as one of the five European Society of Human Reproduction and Embryology (ESHRE) Young Ambassadors. She will be reporting from the ESHRE 40th Annual Meeting, taking place in Amsterdam, The Netherlands, from 7-10 July 2024. The ESHRE Annual Meeting is a scientific event that inspires scientists and healthcare professionals alike, bringing together experts from around the world to share the latest research and advancements in reproductive medicine and embryology. Sarah Harden, PhD, AFHEA is a highly motivated scientist committed to advancing women’s health. She earned her PhD in Molecular Biomedicine from the University of Warwick in 2023, focusing on metabolic regulation in endometrial cells and its link to recurrent miscarriage. She, additionally, explored the interplay between autoimmunity and endometriosis. Dr. Harden is a passionate scientific communicator and a dedicated mentor for future scientists. Please join us in congratulating Dr. Harden on this remarkable achievement! #ESHRE2024 #womenshealth #endometriosisresearch #endogene
-
Thank you, Genopole for your support during this trip! It was a very productive meeting, where we got to meet a lot of new wonderful people, but also catch up with old friends!
🌍 Genopole back in San Diego for #BIO2024 !! 🌍 #BIO2024: The dynamism of the Paris Region ecosystem is palpable at the France pavilion with a large number of visitors at our booth #3823 hall E! We’re looking forward to connecting and exploring new opportunities together during this week of networking. A big thank you to our partners: Région Île-de-France French Healthcare Choose Paris Region Medicen Paris Region Business France Business France North America Institut Pasteur France BioLead The Genopole team is proud to represent the companies in our ecosystem and continues to expand its network of investors, international groups, and partner clusters. Lacroix L., Stéphane SOUM, Alexis Biton. The companies supported by Genopole through the Gene.io programs have had the opportunity to secure qualified meetings with major accounts for promising co-development projects: Héloïse Mailhac, co-founder of STH BIOTECH Sakina Elkassouani, co-founder of Alt Biotech María Teresa Pérez Zaballos, co-founder of EndoGene.Bio Be sure to connect with us to learn about the French leading life sciences cluster ! Yann Masson Silvia Paolella, Linda Nait, Alexandre Batch, PhD - MBA, Jean-Charles Moczarski, Valérie Hélin, PhD, Elodie Thierion Hélène Sire David Del Bourgo, Antoine PRESTAT Lise ALTER Laurent LAFFERRÈRE, PhD, eMBA #Innovation #Biotech #Genopole #Collaboration #Investors #Ecosystem #ParisRegion
-
Our CEO is heading to San Diego for the BIO International Convention. If you are interested in female health drug development and diagnostics, we’d love to chat!!
I am heading to San Diego for the BIO International Convention with Genopole next week. I would love to meet people in the female health drug development and diagnostic space, people working in analytic labs and investors. Let me know if you’d like to speak! 🙋🏻♀️
-
Un grand merci à Femtech France pour cette reconnaissance et pour tout le travail qu'elles réalisent afin de cartographier, soutenir et encourager le développement et la consolidation de l'écosystème. Votre travail nous aide a toutes. Merci 💜 https://lnkd.in/eMcYJeRn
-
📣 EndoGene.Bio is hiring!
-
endogene.bio a republié ceci
🚨 We are #hiring! EndoGene.Bio is looking for a talented #BioinformaticsScientist to contribute to our #multiomics analysis efforts for improving #womenshealth. This is a #hybrid or #remote job available to start ASAP. If interested, check the details in the advert below 👇 #nowhiring #bioinformaticsjobs #bioinformaticianjobs #bioinformatics #computationalbiology #sciencejobs #jobadvert #endometriosis